Urinary bisphenol A concentrations and ovarian response among women undergoing IVF
- PMID: 20002217
- PMCID: PMC3089904
- DOI: 10.1111/j.1365-2605.2009.01014.x
Urinary bisphenol A concentrations and ovarian response among women undergoing IVF
Abstract
Bisphenol A (BPA) is a synthetic chemical used in the manufacture of materials present in many common consumer products. In experimental animals, BPA caused oocyte aneuploidy and reduced production of oestradiol. In a prospective cohort study, we investigated the association between urinary BPA concentrations and ovarian response among women undergoing in vitro fertilization (IVF) at the Massachusetts General Hospital (MGH) Fertility Center. The geometric mean of two specific-gravity (SG) adjusted urinary BPA concentrations collected during each IVF cycle was used as the cycle-specific BPA exposure level. BPA concentrations were measured using online solid phase extraction coupled to isotope dilution-high-performance liquid chromatography-tandem mass spectrometry. Peak serum oestradiol was measured using the Elecsys Estradiol II immunoassay kit. Multivariable mixed effect models and Poisson regression models adjusting for correlation between multiple IVF cycles in the same woman were used to evaluate the association between urinary BPA concentrations and ovarian response, adjusting for age, BMI and day 3 follicle stimulating hormone (FSH) levels, a clinical measure of ovarian reserve. Urinary BPA concentrations were measured in 84 women (mean age 35.6 years) undergoing 112 IVF cycles; 23 women (27%) contributed more than one IVF cycle. BPA concentrations ranged from <0.4 to 25.5 microg/L (geometric mean 2.52 +/- SD 3.2); 15% of urine samples had concentrations <0.4 microg/L. Peak serum oestradiol levels correlated with the total number of oocytes retrieved per cycle (r = 0.65, p < 0.001). For each log unit increase in SG-BPA, there was an average decrease of 12% (95% CI: 4, 23%; p = 0.007) in the number of oocytes retrieved and an average decrease of 213 pg/ml (95% CI: -407, -20; p = 0.03) in peak oestradiol. BPA was detected in the urine of the majority of women undergoing IVF, and was inversely associated with number of oocytes retrieved and peak oestradiol levels.
Similar articles
-
Urinary bisphenol A concentrations and association with in vitro fertilization outcomes among women from a fertility clinic.Hum Reprod. 2015 Sep;30(9):2120-8. doi: 10.1093/humrep/dev183. Epub 2015 Jul 24. Hum Reprod. 2015. PMID: 26209788 Free PMC article.
-
The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments.Reprod Toxicol. 2013 Dec;42:224-31. doi: 10.1016/j.reprotox.2013.09.008. Epub 2013 Oct 4. Reprod Toxicol. 2013. PMID: 24100206 Free PMC article.
-
Urinary bisphenol A concentration is correlated with poorer oocyte retrieval and embryo implantation outcomes in patients with tubal factor infertility undergoing in vitro fertilisation.Ecotoxicol Environ Saf. 2020 Jan 15;187:109816. doi: 10.1016/j.ecoenv.2019.109816. Epub 2019 Oct 21. Ecotoxicol Environ Saf. 2020. PMID: 31648075
-
Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization.Environ Health Perspect. 2012 Jul;120(7):978-83. doi: 10.1289/ehp.1104307. Epub 2012 Apr 6. Environ Health Perspect. 2012. PMID: 22484414 Free PMC article.
-
Urinary concentrations of bisphenol A, parabens and phthalate metabolite mixtures in relation to reproductive success among women undergoing in vitro fertilization.Environ Int. 2019 May;126:355-362. doi: 10.1016/j.envint.2019.02.025. Epub 2019 Feb 28. Environ Int. 2019. PMID: 30826614 Free PMC article.
Cited by
-
Exposure to Power-Frequency Magnetic Fields and the Risk of Infertility and Adverse Pregnancy Outcomes: Update on the Human Evidence and Recommendations for Future Study Designs.J Toxicol Environ Health B Crit Rev. 2016;19(1):29-45. doi: 10.1080/10937404.2015.1134370. J Toxicol Environ Health B Crit Rev. 2016. PMID: 27030583 Free PMC article. Review.
-
Urinary Organophosphate Metabolite Concentrations and Pregnancy Outcomes among Women Conceiving through in Vitro Fertilization in Shanghai, China.Environ Health Perspect. 2020 Sep;128(9):97007. doi: 10.1289/EHP7076. Epub 2020 Sep 30. Environ Health Perspect. 2020. PMID: 32997523 Free PMC article.
-
The Role of Endocrine Disrupting Chemicals in Gestation and Pregnancy Outcomes.Nutrients. 2023 Nov 3;15(21):4657. doi: 10.3390/nu15214657. Nutrients. 2023. PMID: 37960310 Free PMC article. Review.
-
Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.Front Neuroendocrinol. 2010 Oct;31(4):420-39. doi: 10.1016/j.yfrne.2010.06.003. Epub 2010 Jul 4. Front Neuroendocrinol. 2010. PMID: 20609371 Free PMC article. Review.
-
Urinary concentrations of benzophenone-3 and reproductive outcomes among women undergoing infertility treatment with assisted reproductive technologies.Sci Total Environ. 2019 Aug 15;678:390-398. doi: 10.1016/j.scitotenv.2019.04.452. Epub 2019 May 2. Sci Total Environ. 2019. PMID: 31077917 Free PMC article.
References
-
- Bae B, Jeong JH, Lee SJ. The quantification and characterization of endocrine disruptor bisphenol-A leaching from epoxy resin. Water Science and Technology. 2002;46:381–387. - PubMed
-
- Boeniger MF, Lowry LK, Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. American Industrial Hygiene Association Journal. 1993;54:615–627. - PubMed
-
- Brede C, Fjeldal P, Skjevrak I, Herikstad H. Increased migration levels of bisphenol A from polycarbonate baby bottles after dishwashing, boiling and brushing. Food Additives and Contaminants. 2003;20:684–689. - PubMed
-
- Can A, Semiz O, Cinar O. Bisphenol-A induces cell cycle delay and alters centrosome and spindle microtubular organization in oocytes during meiosis. Molecular Human Reproduction. 2005;11:389–396. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical